Arvinas ARVN
NASDAQ ARVN
$9.39 +0.08 (+0.86%)
As of: Sep 4, 2026 · 3:59 PM EDT

Arvinas (ARVN) EBT Margin (2017 - 2026)

Arvinas (ARVN) posted quarterly EBT Margin of 368.59% for Q1 2026, down 41260.0% year-over-year from N/an in Q1 2025, and up 47.89% quarter-over-quarter from 707.37% in Q4 2025.

Analysis

Arvinas (ARVN) EBT Margin (2017 - 2026) Analysis & Trends

Arvinas' EBT Margin history runs 10 years deep, the most recent figure standing at 368.59% for Q1 2026.

  • In Q1 2026, EBT Margin fell 41260.0% year-over-year to 368.59%; the TTM figure through Mar 2026 stood at 247.2% (down 23643.0% YoY), while the FY2025 annual figure was 30.65%, up 4463.0% from the prior year.
  • EBT Margin for Q1 2026 stood at 368.59%, up from 707.37% in the prior quarter.
  • The five-year high for EBT Margin was 355.45% in Q4 2023, with the low at 707.37% in Q4 2025.
  • The 5-year median for EBT Margin is 184.04% (2022), against an average of 164.92%.
  • The sharpest annual moves came in 2022 and 2025: EBT Margin surged 72490 bps in 2022, then plunged 63051 bps in 2025.
  • Arvinas' EBT Margin stood at 183.33% in 2022, then jumped by 294 bps to 355.45% in 2023, then sank by 122 bps to 76.86% in 2024, then sank by 820 bps to 707.37% in 2025, then surged by 48 bps to 368.59% in 2026.
  • Business Quant data shows ARVN's EBT Margin at 368.59% in Q1 2026, 707.37% in Q4 2025, and 83.05% in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 41.75%
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 35.61%
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 35.78%
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -528.97%
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 18.33%
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 13.77%
8 Royalty Pharma 28.45 Bn 27.61 Bn - 12.09%
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -2.67%
10 Arvinas 609.77 Mn 41.87 Mn - 67.92%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 67.92%
Mar 31, 2026 -368.59%
Dec 31, 2025 -707.37%
Sep 30, 2025 -83.05%
Jun 30, 2025 -274.55%
Mar 31, 2025 44.01%
Dec 31, 2024 -76.86%
Sep 30, 2024 -47.46%
Jun 30, 2024 -45.75%
Mar 31, 2024 -273.91%
Dec 31, 2023 355.45%
Sep 30, 2023 -184.68%
Jun 30, 2023 -120.37%
Mar 31, 2023 -249.85%
Dec 31, 2022 -183.33%
Sep 30, 2022 -184.04%
Jun 30, 2022 -189.64%
Mar 31, 2022 -213.58%
Dec 31, 2021 -138.86%
Sep 30, 2021 -503.23%